No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Lake Street Initiates Coverage On Lifevantage With Buy Rating, Announces Price Target of $26
Lifevantage Analyst Ratings
"Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
LifeVantage to Participate in the Water Tower Fireside Chat Series
LifeVantage Unveils Lip Care Favorite Back for Cyber Monday